NRA-ARIPIPRAZOLE TABLET Canada - English - Health Canada

nra-aripiprazole tablet

nora pharma inc - aripiprazole - tablet - 15mg - aripiprazole 15mg

NRA-ARIPIPRAZOLE TABLET Canada - English - Health Canada

nra-aripiprazole tablet

nora pharma inc - aripiprazole - tablet - 20mg - aripiprazole 20mg

NRA-ARIPIPRAZOLE TABLET Canada - English - Health Canada

nra-aripiprazole tablet

nora pharma inc - aripiprazole - tablet - 2mg - aripiprazole 2mg

ARIPIPRAZOLE TABLET Canada - English - Health Canada

aripiprazole tablet

sanis health inc - aripiprazole - tablet - 30mg - aripiprazole 30mg - atypical antipsychotics

ARIPIPRAZOLE TABLET Canada - English - Health Canada

aripiprazole tablet

sivem pharmaceuticals ulc - aripiprazole - tablet - 30mg - aripiprazole 30mg

Aripiprazole 30 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

aripiprazole 30 mg tablets

bristol laboratories limited - aripiprazole - tablet - 30 milligram(s) - other antipsychotics; aripiprazole

Aripiprazole 30 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

aripiprazole 30 mg tablets

brillpharma (ireland) limited - aripiprazole - tablet - 30 milligram(s) - other antipsychotics; aripiprazole

ARIPIPRAZOLE SANDOZ 10 Israel - English - Ministry of Health

aripiprazole sandoz 10

novartis israel ltd - aripiprazole - tablets - aripiprazole 10 mg - aripiprazole - aripiprazole sandoz is indicated for the treatment of schizophrenia, for the treatment of moderate to severe manic episodes in bipolar i disorder and for the prevention of a new manic episode in patient who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.aripiprazole sandoz is indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (mdd). efficacy was established in two 6-week trials in adults with mdd who had an inadequate response to antidepressant therapy during the current episode.aripiprazole sandoz is indicated for the treatment of irritability associated with autistic disorder. efficacy was established in two 8-week trials in pediatric patients (aged 6 to 17 years) with irritability associated with autistic disorder (including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods).

ARIPIPRAZOLE SANDOZ 10 Israel - English - Ministry of Health

aripiprazole sandoz 10

novartis israel ltd - aripiprazole - tablets - aripiprazole 10 mg - aripiprazole - aripiprazole sandoz is indicated for the treatment of schizophrenia, for the treatment of moderate to severe manic episodes in bipolar i disorder and for the prevention of a new manic episode in patient who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.aripiprazole sandoz is indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (mdd). efficacy was established in two 6-week trials in adults with mdd who had an inadequate response to antidepressant therapy during the current episode.aripiprazole sandoz is indicated for the treatment of irritability associated with autistic disorder. efficacy was established in two 8-week trials in pediatric patients (aged 6 to 17 years) with irritability associated with autistic disorder (including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods).

ARIPIPRAZOLE SANDOZ 15 Israel - English - Ministry of Health

aripiprazole sandoz 15

novartis israel ltd - aripiprazole - tablets - aripiprazole 15 mg - aripiprazole - aripiprazole sandoz is indicated for the treatment of schizophrenia, for the treatment of moderate to severe manic episodes in bipolar i disorder and for the prevention of a new manic episode in patient who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.aripiprazole sandoz is indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (mdd). efficacy was established in two 6-week trials in adults with mdd who had an inadequate response to antidepressant therapy during the current episode.aripiprazole sandoz is indicated for the treatment of irritability associated with autistic disorder. efficacy was established in two 8-week trials in pediatric patients (aged 6 to 17 years) with irritability associated with autistic disorder (including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods).